Skip to main content

COVID-19 Hydroxychloroquine Trial

St. Francis Hospital, The Heart Center® Launches Outpatient Covid-19 Hydroxychloroquine Trial

If you have questions or are interested, please contact us at: (516) 414-3056, research.volunteer@chsli.org.

Now enrolling qualifying outpatients

Recent studies suggest that early intervention with hydroxychloroquine and zinc has benefit and seems to be safe even in hospitalized patients, while late administration in critically-ill patients has little efficacy and may be harmful. We have launched a clinical trial at St. Francis Hospital using these potentially helpful agents in non-hospitalized patients with early COVID-19 symptoms to try to gain maximum benefit from this treatment. Our protocol emphasizes safety, with cardiologists at St. Francis Hospital remotely monitoring the EKG for everyone participating in the study. Patients can be enrolled remotely, allowing people from across the country access to this protocol. All medications and a Kardia EKG monitor are provided free of charge.

We encourage people who have COVID-19 symptoms to test early and take advantage of all therapeutic options that may be available.

Have you been diagnosed with COVID-19 in the past 48-hours?

You can participate in the trial from the comfort of your home.

  • Seeking individuals age 30 and over with recent onset COVID-19 symptoms and/or a positive COVID-19 test within the prior 2 days.
  • High risk individuals without contraindications will be enrolled.
  • All participants enrolled will receive medications free of charge.
  • All participants enrolled will receive a portable EKG device to monitor their heart at home.
  • All participants will receive regular follow-up phone calls from our research nurses.

"The medications we’re using in this trial have shown promise in outpatients treated early after onset of COVID-19 symptoms," says Avni Thakore, MD, Chief Medical Officer, CHS Physicians Partners Medical Group. "Our randomized clinical trial will help determine the effectiveness of this much discussed treatment."

If you have questions or are interested in this protocol, please contact us at: (516) 414-3056, research.volunteer@chsli.org.

Related reading:

Theory on why Zinc and Hydroxychloroquine may work

Zinc inhibiting viral replication

Chloroquine as a zinc channel

Effects on Chloroquine on virus

Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone

Share